Overview
Epigenomics is the genome-wide study of epigenetic modifications — chemical changes to DNA and chromatin that regulate gene expression without altering the underlying DNA sequence. These modifications include DNA methylation at CpG dinucleotides, post-translational histone modifications (such as acetylation, methylation, and phosphorylation), and chromatin accessibility patterns. Epigenomic maps vary across cell types, developmental stages, and disease states, providing a dynamic layer of information that complements the static genome. Large-scale projects such as the ENCODE and Roadmap Epigenomics consortia have produced comprehensive epigenomic atlases for hundreds of human cell types.
Methods
Epigenomic profiling relies on techniques adapted for high-throughput sequencing. Whole-genome bisulfite sequencing (WGBS) converts unmethylated cytosines to uracil, allowing single-base resolution methylation maps. ChIP-seq uses antibodies to immunoprecipitate specific histone modifications or transcription factor-bound regions, followed by sequencing. ATAC-seq and DNase-seq map open chromatin regions to identify active regulatory elements. Hi-C and related methods capture three-dimensional chromatin conformation. Bioinformatics pipelines process raw reads through alignment, peak calling (using MACS2 or PeakDene), and differential enrichment analysis. Integrative analysis combining multiple epigenomic tracks reveals chromatin states — such as active promoters, enhancers, and repressed regions — using tools like ChromHMM.
Applications
Epigenomics has transformed our understanding of development, aging, and disease. Aberrant DNA methylation patterns are hallmarks of cancer, with tumor suppressor gene silencing by promoter hypermethylation now a therapeutic target. Epigenomic profiling guides the discovery of enhancers and other regulatory elements studied in gene regulation and epigenetics. The technique is closely related to chromatin immunoprecipitation (ChIP) but scaled to the entire genome. Epigenomics also illuminates how DNA replication timing correlates with chromatin state, and how environmental exposures leave lasting epigenetic marks that influence health outcomes across the lifespan.
